Detection of the factor V(Leiden) mutation: Development of a testing algorithm combining a coagulation assay and molecular diagnosis

American Journal of Clinical Pathology

Volumn 108, Issue 4, 1997, Pages 427-433

  Wasserman, Linda M ^a   Roger Edson, J ^b   Key, Nigel S ^b   Chibbar, Rajni ^b   McGlennen, Ronald C ^b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Activated protein C resistance; Factor V(Leiden) mutation; Molecular diagnosis

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 8; DNA; BLOOD CLOTTING FACTOR 5 LEIDEN; PROTEIN C;

ALGORITHM; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; STANDARD; THROMBOPHILIA; ADULT; BLOOD CLOTTING TEST; GENETICS; METABOLISM; METHODOLOGY; MUTATION; POLYMERASE CHAIN REACTION; PREDICTION AND FORECASTING; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY;

ADULT; ALGORITHMS; BLOOD COAGULATION TESTS; DNA; FACTOR V; FACTOR VIII; FEMALE; HUMANS; MALE; MUTATION; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; PROTEIN C; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY;

EID: 0030610756     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/108.4.427     Document Type: Article

References (8)

1. Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci U S A. 1993;90:1004-1008.
2. Griffin JH, Evatt, B, Wideman, C, Fernandez JA. Anticoagulant protein C pathway defective in majority of thrombophilic patients. Blood. 1993;82:1989-1993.
3. Sun X, Evatt B, Griffin JH. Blood coagulation factor Va abnormality associated with resistance to activated protein C in venous thrombophilia. Blood. 1994;83:3120-3125.
4. Bertina RM, Koeleman BPC, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369:64-67.
5. Zöller, B, Dahlbäck B. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet. 1994;343:1536-1538.
6. Griffin J, Heeb M, Kojima Y, et al. Activated protein C resistance: molecular mechanisms. Thromb Haemost. 1995;74:444-448.
7. Dahlbäck B. Inherited thrombophilia: resistance to activated protein C as a pathogenic factor of venous thromboembolism. Blood. 1995;85:607-614.
8. Bell WN, Alton HG. A brain extract as a substitute for platelet suspensions in the thromboplastin generation test. Nature. 1954;174:880-881.